Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company reported a net profit attributable to shareholders of CNY 154.08 billion for 2025, representing a year-on-year increase of 44.1%. However, the Q4 net profit was a loss of CNY 13.73 billion, primarily due to adjustments in the capital market [2] - The company's embedded value reached CNY 1.47 trillion, up 4.8% year-on-year, while the new business value (NBV) was CNY 45.75 billion, reflecting a 35.7% increase [2] - The company plans to distribute a cash dividend of CNY 0.618 per share for the end of 2025, which, combined with the interim dividend, totals CNY 0.856 per share for the year, amounting to approximately CNY 24.2 billion, or 16% of the net profit [2] Summary by Sections New Business Value (NBV) - The company achieved a new business value of CNY 45.75 billion in 2025, a 35.7% increase year-on-year. The growth rates for Q1, H1, and Q1-3 were +4.8%, +20.3%, and +41.8% respectively. The new single premium was CNY 234.08 billion, up 9.3% year-on-year [3] - The individual insurance channel's NBV increased by 25.5% to CNY 39.30 billion, while other channels saw a 169.3% increase to CNY 6.45 billion, contributing 14% to the total NBV [3] Investment Performance - As of the end of the reporting period, the company's investment assets totaled CNY 7.42 trillion, a 12.3% increase from the beginning of the year. The total investment income was CNY 387.69 billion, a 25.8% increase year-on-year, while net investment income decreased by 1.0% to CNY 193.80 billion [4] - The total investment return rate reached 6.09%, an increase of 0.6 percentage points year-on-year [4] Financial Forecasts - The company maintains its forecasts for insurance service revenue at CNY 220.5 billion for 2026 and CNY 230.4 billion for 2027, with a new forecast of CNY 239.1 billion for 2028. The net profit forecasts are CNY 130.4 billion for 2026 and CNY 133.3 billion for 2027, with a new forecast of CNY 135.0 billion for 2028 [5] - The earnings per share (EPS) forecasts are CNY 4.61 for 2026, CNY 4.72 for 2027, and CNY 4.78 for 2028 [5]

Summary of Key Points from the Conference Call Company Overview - **Company**: China Life Insurance - **Industry**: Life Insurance Core Insights and Arguments 1. **2025 Performance Highlights**: - Achieved record high performance since 2018 with total investment return rate of 6.09%, up 25.8% year-on-year - Proposed dividend of 24.2 billion yuan, an increase of 32% year-on-year [2][13] - Individual insurance channel contributed 85% of new business value, with growth capability up 40% year-on-year [2] 2. **Investment Strategy**: - Increased equity investment ratio by nearly 5 percentage points, exceeding 1.2 trillion yuan, focusing on technology and high-dividend stocks [2] - Alternative investment scale exceeded 1 trillion yuan, with a strategic shift towards equity rather than value decline [2][6] - Focused on sectors like AI, semiconductors, health, and green energy through private equity funds, nurturing 22 listed companies with a total market value exceeding 1 trillion yuan [2][8] 3. **Reform Initiatives for 2026**: - Five key reform areas: digital transformation, management model upgrade, multi-channel development, customer management, and investment capability enhancement [4][5] - Emphasis on digital integration in product design, sales, and risk management to drive high-quality growth [5] 4. **Long-term Care Insurance and Health Insurance**: - Actively participating in long-term care insurance projects since 2016, with over 70 pilot projects [12] - Health insurance premium income exceeded 120 billion yuan in 2025, with plans for diversified product offerings and improved service integration [12] 5. **Market Position and Future Outlook**: - Aiming to become a world-class life insurance company by enhancing value creation capabilities and digital transformation [19] - Anticipating continued strong growth in 2026, with a focus on optimizing business structure and enhancing value creation [3][20] Additional Important Content 1. **Geopolitical Risks**: - Minimal impact from geopolitical risks due to low exposure in overseas investments (<0.89% of total assets) [10][11] - Monitoring global geopolitical developments and their potential effects on energy prices and inflation expectations [10] 2. **Investment Performance Drivers**: - Strong investment performance attributed to China's high-quality economic development and a stable capital market [8] - Strategic asset allocation adjustments to capture market opportunities, including increased allocation to high-dividend stocks [8] 3. **Dividend Policy**: - Committed to stable and improving dividend levels, with a total market value exceeding 1.1 trillion yuan, up 16% from the beginning of the year [14] 4. **Challenges in Individual Insurance Channel**: - Individual insurance channel showed slower growth in new single premiums, but remains a core channel contributing significantly to new business value [20] 5. **Real Estate Investment Trends**: - Investment in real estate remains below 2% of total investment assets, with a focus on core assets in major cities [17][18] This summary encapsulates the key points discussed in the conference call, highlighting the company's performance, strategic initiatives, and outlook for the future.

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][8] Core Views - The company's performance for 2025 met expectations, with a year-on-year increase in net profit attributable to shareholders of 44.1% to 154.1 billion yuan, although the growth rate decreased by 16.5 percentage points compared to the previous three quarters due to significant increases in the second half of 2025 and capital market fluctuations in the fourth quarter [5] - The company has increased its allocation to equity in the secondary market to 17%, with a total investment asset scale of 7.42 trillion yuan, reflecting a year-on-year growth of 12.3% [7] - The company has adjusted its profit forecast downwards due to increased capital market volatility and geopolitical risks, with expected net profits for 2026-2028 revised to 164.24 billion, 186.28 billion, and 222.85 billion yuan respectively [8] Financial Performance - The company's total revenue for 2025 was 615.68 billion yuan, with a year-on-year growth rate of 16.48% [9] - The net profit attributable to shareholders for 2025 was 154.08 billion yuan, with a year-on-year growth rate of 44.09% [9] - The company’s earnings per share for 2025 is projected to be 5.45 yuan, with a price-to-earnings ratio of 7.24 [9] Investment Analysis - The company has seen a significant increase in new business value (NBV), which rose by 35.7% year-on-year to 45.75 billion yuan, slightly above expectations [6] - The contribution from the bancassurance channel has been substantial, with a year-on-year increase of 169.3% in NBV to 6.45 billion yuan [10] - The company has maintained a dividend payout ratio of 15.7%, with an annual dividend of 0.856 yuan, reflecting a year-on-year increase of 31.7% [5]

Market Overview - The A-share market experienced a collective decline today, with the Shanghai Composite Index falling by 1.09% to close at 3889.08 points, the Shenzhen Component Index down 1.41% to 13606.44 points, and the ChiNext Index decreasing by 1.34% to 3272.49 points. The total trading volume in the Shanghai and Shenzhen markets was 195.71 billion, a decrease of 23.59 billion compared to the previous day [3]. Market Sentiment and Performance - The core factors influencing market trading include short-term sentiment, mid-term performance, and long-term valuation. Currently, during the annual report disclosure season, market sentiment is the key driver of investment trading. Many companies reported annual results that exceeded expectations but still performed poorly due to a lack of growth expectations. Conversely, companies with disappointing results faced significant declines. Overall, market sentiment is cautious, leading to a conservative outlook for the future, which results in a tendency for stocks to decline regardless of whether their performance is above or below expectations [4]. Insurance Sector Analysis - The insurance sector was notably impacted today, particularly due to the annual report disclosure of China Life Insurance. Despite a 44% growth in retail business performance, the stock price fell sharply due to over 10 billion yuan in investment losses in the fourth quarter. Comparatively, China Life's third-quarter performance showed a 60% year-on-year increase, leading the market to view the annual report as underwhelming, which directly contributed to the stock's decline. Similarly, China Ping An reported a 22% year-on-year increase in net profit, with a significant improvement from an 11% increase in the third quarter. However, its stock also experienced a substantial drop, making its future performance a critical indicator for market sentiment. From a valuation perspective, China Ping An's annual dividend is 2.7 yuan per share, with a current stock price of 56 yuan, indicating a high investment value in terms of dividend yield [5][6]. Long-term Valuation Perspective - From a long-term valuation standpoint, the fundamentals of the insurance sector remain positive, particularly with significant growth in premium income this year. However, short-term trends are still heavily influenced by market sentiment. The A-share market showed a retracement today, with over 4000 stocks declining and only about 900 stocks rising, indicating a broad market downturn. The sectors leading the decline included wind power, solar energy, and insurance, while the oil service sector benefited from a rebound in oil prices [6]. Market Outlook - Currently, both the A-share market and the Hang Seng Technology Index are awaiting the resolution of negative sentiment. The ongoing disclosure of annual reports from major companies may serve as a pivotal point for the market. This turning point could not only impact individual stocks but also help establish a clear direction for the overall market trend [7].

Core Viewpoint - The article discusses the increasing attention and activity in the S fund market, highlighting China Life's significant investment in a new S fund as part of a broader trend of diversified exit strategies in the private equity sector [4][11]. Group 1: Investment Activities - China Life Insurance Company announced a commitment of 2.8 billion RMB to establish the Fujian Xinxin Rui Science and Technology Innovation Equity Investment Fund, with a total planned contribution of approximately 4.0154 billion RMB [8]. - In addition to the new S fund, China Life has made substantial investments earlier in the year, totaling 15.3 billion RMB across multiple private equity funds, including a 12.492 billion RMB investment in a Yangtze River Delta innovation fund and an 8.4915 billion RMB investment in a second phase of a pension industry fund [10]. Group 2: Market Trends - The S fund market has seen a significant increase in activity, with a report indicating that the total transaction volume in China's private equity secondary market reached approximately 92.3 billion RMB by Q3 2025, marking a 182% year-on-year increase [14]. - The number of transactions also surged, with 867 deals recorded, reflecting a 234% increase compared to the previous year, indicating a growing interest and participation in the S market [14]. - The article notes that government funds and financial institutions are the primary participants in the S market, driven by a deeper understanding of S transactions among various stakeholders [14]. Group 3: Future Outlook - The article suggests that the S fund is evolving from an emergency tool to a crucial component of exit strategies, with the potential for GP and LP to have more options as the market matures [19]. - The ongoing development of the S market is expected to lead to a more diversified and mature investment landscape, reflecting a shift in attitudes from resistance to proactive engagement with S funds [19].

Investment Rating - The report maintains a "Buy" rating for China Life Insurance (601628) [2][8] Core Views - The company's performance for 2025 met expectations, with a year-on-year increase in net profit attributable to shareholders of 44.1% to 154.1 billion yuan, although the growth rate decreased by 16.5 percentage points compared to the previous three quarters due to significant increases in the second half of 2025 and capital market fluctuations in the fourth quarter [5] - The company has increased its allocation to equity investments in the secondary market to 17%, with a total investment asset scale of 7.42 trillion yuan, reflecting a year-on-year growth of 12.3% [7] - The report projects a downward adjustment in profit forecasts for 2026-2028, estimating net profits of 164.24 billion yuan, 186.28 billion yuan, and 222.85 billion yuan respectively, due to increased capital market volatility and geopolitical risks [8] Financial Data Summary - For 2025, the company reported a total revenue of 615.68 billion yuan, with a year-on-year growth rate of 16.48% [9] - The net profit attributable to shareholders for 2025 was 154.08 billion yuan, reflecting a year-on-year growth of 44.09% [9] - The earnings per share for 2025 is projected at 5.45 yuan, with a price-to-earnings ratio of 7.24 [9] Investment Analysis - The company has shown a robust increase in new business value (NBV), with a year-on-year growth of 35.7% to 45.75 billion yuan, slightly exceeding expectations [6] - The contribution from bancassurance has significantly increased, with a year-on-year growth of 169.3% in non-individual insurance channel NBV [10] - The report highlights a strategic shift towards equity investments, with the proportion of equity and fund allocations increasing by 4.7 percentage points to 16.9% [7]

Core Viewpoint - China Life Insurance Company reported a net profit growth of 44.1% year-on-year for 2025, but experienced a net loss in the fourth quarter, attributed to structural adjustments in the capital market affecting its stock and fund holdings. The management emphasized that these fluctuations are mostly temporary and do not reflect the company's long-term operational trends [3][4]. Group 1: Financial Performance - For the first three quarters of 2025, China Life achieved a net profit attributable to shareholders of 167.8 billion yuan, a year-on-year increase of 60.5%. The total net profit for the year was 154.1 billion yuan, reflecting a growth of 44.1% [3]. - The total investment income for 2025 reached 387.7 billion yuan, an increase of 79.4 billion yuan compared to the same period in 2024. The total investment return rate was 6.09%, up by 59 basis points from the previous year [4]. Group 2: Investment Strategy - As of December 31, 2025, China Life's investment assets amounted to 7.42 trillion yuan, representing a growth of 12.3% from the end of 2024. The allocation ratio of stocks and funds (excluding money market funds) increased from 12.18% at the end of 2024 to 16.89%, indicating a strategic increase in equity investments [4]. - The company is closely monitoring global geopolitical risks, particularly those arising from the US-Iran conflict, although the impact on its overall assets is minimal due to the small scale of its overseas asset allocation. The company plans to leverage its long-term capital stability to dynamically adjust its asset allocation strategy [4].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has demonstrated significant results from its product diversification transformation, with dividends achieving high growth for two consecutive years [1] - The company’s net profit attributable to shareholders for 2025 is projected at 154.1 billion yuan, representing a year-on-year increase of 44% [1] - The company’s investment performance is expected to benefit from equity allocation, while the liability side is anticipated to maintain healthy growth in the medium to long term [1] Financial Performance Summary - Total premium income for 2025 reached 729.9 billion yuan, up 8.7% year-on-year, with new business premiums at 234.1 billion yuan, increasing by 9.3% [2] - The company achieved a new business value (NBV) of 45.8 billion yuan in 2025, reflecting a year-on-year growth of 36% [2] - The investment assets of the company reached 7.42 trillion yuan in 2025, a 12% increase year-on-year, with net investment income of 193.8 billion yuan, down 1% from the previous year [3] Financial Projections - The company’s projected net profit for 2026 is 168 billion yuan, with a year-on-year growth of 9%, and for 2027, it is expected to reach 177.6 billion yuan, growing by 5.8% [1][4] - The embedded value (EV) at the end of 2025 is estimated at 1.47 trillion yuan, a 4.8% increase from the beginning of the year [1] - The company plans to distribute a dividend of 0.856 yuan per share for the year, which is a 32% increase year-on-year, resulting in a static dividend yield of 2.2% at the current stock price [1]

Investment Rating - The report maintains a "Buy" rating for China Life Insurance (601628) with a target price of 53.41 CNY [6][13]. Core Insights - The company achieved a net profit growth of 44.1% year-on-year for 2025, with net assets increasing by 16.8% from the beginning of the year, driven by improvements in both insurance and investment performance [3][13]. - The report highlights a significant increase in the proportion of equity investments, with total investment assets reaching 7.4 trillion CNY, a 12.3% year-on-year increase, and the share of stocks and funds rising to 16.9%, up 4.7% [13]. - The new business value (NBV) grew by 35.7% in 2025, with individual insurance and bancassurance segments showing year-on-year increases of 25.5% and 169.3%, respectively [13]. Financial Summary - Revenue for 2025 is projected at 615.678 billion CNY, reflecting a 16% increase from 2024 [5]. - The net profit attributable to shareholders is expected to reach 154.078 billion CNY in 2025, marking a 44% increase compared to 2024 [5]. - Earnings per share (EPS) for 2025 is forecasted at 5.45 CNY, with a projected net asset return rate of 26% [5][14]. Business Performance - The report indicates that the company's insurance service revenue is expected to grow to 214.136 billion CNY in 2025, with a slight increase in insurance service expenses [14]. - The investment income is projected to rise to 198.457 billion CNY in 2025, benefiting from improved market conditions [14]. - The company’s solvency ratios are reported at 128.8% for core solvency and 174.0% for comprehensive solvency, although these figures have decreased year-on-year [13].

Investment Rating - The report assigns a "Buy-A/Buy-H" rating for the company [3] Core Views - The company's performance and value are both strong, with dividend growth exceeding expectations [1] - The net profit for 2025 increased by 44.1% year-on-year, driven by market upturns and increased equity allocation [12][44] - The new business value (NBV) grew by 35.7% year-on-year, supported by a strong demand for savings products and improved distribution channels [30][46] Financial Forecast - Embedded Value (CNY million) is projected to grow from 1,401,146 in 2024 to 1,960,695 in 2028, with a growth rate of 11.2% in 2024 [2] - Net profit is expected to reach 106,935 million in 2024, with a significant increase of 131.56% year-on-year [2] - Earnings per share (EPS) is forecasted to be 3.78 in 2024, increasing to 6.01 by 2028 [2] Performance Analysis - The company's total investment assets reached 7.42 trillion, a 12.3% increase year-on-year, with a notable rise in equity investments [22] - The total investment return for 2025 was 6.1%, reflecting a 0.6 percentage point increase from the previous year [25] - The company’s net investment yield was 3% in 2025, supported by a higher allocation to high-dividend assets [25] Value Analysis - The NBV for 2025 is projected at 45,752 million, with a year-on-year increase of 35.7% [2][30] - The company's internal value (EV) increased by 4.8% year-on-year, despite negative market value adjustments due to rising interest rates [35][46] - The NBV margin improved to 19.5%, up 3.8 percentage points year-on-year, driven by better pricing and distribution strategies [30][34] Insurance Sector Insights - The company’s agent workforce decreased by 4.6% year-on-year to 587,000, but the quality of agents is improving [41][42] - The company is focusing on enhancing the quality of its sales force while expanding its market presence [41] Profitability Forecast and Investment Recommendations - The report anticipates significant net profit growth, with EPS expected to be 4.42, 5.93, and 6.01 for 2026, 2027, and 2028 respectively [2][44] - The fair value for A-shares is estimated at 56.53 CNY and for H-shares at 38.45 HKD, maintaining a "Buy" rating [44][46]